Improved growth of enteric adenovirus type 40 in a modified cell line that can no longer respond to interferon stimulation

References

1. Andrejeva J., Young D. F., Goodbourn S., Randall R. E. 2002; Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J Virol 76:2159–2167 [CrossRef]
   [Google Scholar]
2. Brandt C. D., Kim H. W., Rodriguez W. J., Arrobio J. O., Jeffries B. C., Stallings E. P., Lewis C., Miles A. J., Gardner M. K., Parrott R. H. 1985; Adenoviruses and pediatric gastroenteritis. J Infect Dis 151:437–443 [CrossRef]
   [Google Scholar]
3. Brown M. 1985; Selection of nonfastidious adenovirus species in 293 cells inoculated with stool specimens containing adenovirus 40. J Clin Microbiol 22:205–209
   [Google Scholar]
4. Brown M., Petric M. 1986; Evaluation of cell line 293 for virus isolation in routine viral diagnosis. J Clin Microbiol 23:704–708
   [Google Scholar]
5. Brown M., Wilson-Friesen H. L., Doane F. 1992; A block in release of progeny virus and a high particle-to-infectious unit ratio contribute to poor growth of enteric adenovirus types 40 and 41 in cell culture. J Virol 66:3198–3205
   [Google Scholar]
6. Chatziandreou N., Young D., Andrejeva J., Goodbourn S., Randall R. E. 2002; Differences in interferon sensitivity and biological properties of two related isolates of simian virus 5: a model for virus persistence. Virology 293:234–242 [CrossRef]
   [Google Scholar]
7. Croyle M. A., Stone M., Amidon G. L., Roessler B. J. 1998; In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine. Gene Ther 5:645–654 [CrossRef]
   [Google Scholar]
8. Didcock L., Young D. F., Goodbourn S., Randall R. E. 1999; The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol 73:9928–9933
   [Google Scholar]
9. Elsing A., Burgert H.-G. 1998; The adenovirus E3/10.4-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization. Proc Natl Acad Sci U S A 9510072–10077 [CrossRef]
   [Google Scholar]
10. Goodbourn S., Didcock L., Randall R. E. 2000; Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81:2341–2364
    [Google Scholar]
11. Graham F. L., Smiley J., Russell W. C., Nairn R. 1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59–74 [CrossRef]
    [Google Scholar]
12. Horvath C. M. 2004; Silencing STATs: lessons from paramyxovirus interferon evasion. Cytokine Growth Factor Rev 15:117–127 [CrossRef]
    [Google Scholar]
13. Kaufman R. J., Murtha P. 1987; Translational control mediated by eucaryotic initiation factor-2 is restricted to specific mRNAs in transfected cells. Mol Cell Biol 7:1568–1571
    [Google Scholar]
14. Look D. C., Roswit W. T., Frick A. G., Gris-Alevy Y., Dicjhaus D. M., Walter M. J., Holtzman M. J. 1998; Direct suppression of Stat1 function during adenoviral infection. Immunity 9:871–880 [CrossRef]
    [Google Scholar]
15. Masson N., Ellis M., Goodbourn S., Lee K. A. W. 1992; Cyclic AMP response element-binding protein and the catalytic subunit of protein kinase A are present in F9 embryonal carcinoma cells but are unable to activate the somatostatin promoter. Mol Cell Biol 12:1096–1106
    [Google Scholar]
16. Mautner V. 1999; Methods for growth and purification of enteric adenovirus type 40. In Adenovirus Methods and Protocols (Methods in Molecular Medicine, vol 21). pp  283–293 Edited by Wold W. S. M. Totowa, NJ: Humana Press;
17. Mautner V., Bailey A., Steinthorsdottir V., Ullah R., Rinaldi A. 1999; Properties of the adenovirus type 40 E1B promoter that contribute to its low transcriptional activity. Virology 265:10–19 [CrossRef]
    [Google Scholar]
18. Philipson L. 1961; Adenovirus assay by the fluorescent cell-counting procedure. Virology 15:263–268 [CrossRef]
    [Google Scholar]
19. Sledz C. A., Holko M., de Veer M. J., Silverman R. H., Williams B. R. 2003; Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5:834–839 [CrossRef]
    [Google Scholar]
20. Takiff H. E., Straus S. E., Garon C. F. 1981; Propagation and in vitro studies of previously non-cultivable enteral adenoviruses in 293 cells. Lancet ii:832–834
    [Google Scholar]
21. Tiemessen C. T., Kidd A. H. 1993; Sensitivity of subgroup F adenoviruses to interferon. Arch Virol 128:1–13 [CrossRef]
    [Google Scholar]
22. Uhnoo I., Wadell G., Svensson L., Johansson M. E. 1984; Importance of enteric adenoviruses 40 and 41 in acute gastroenteritis in infants and young children. J Clin Microbiol 20:365–372
    [Google Scholar]
23. van Loon A. E., Gilardi P., Perricaudet M., Rozijn T. H., Sussenbach J. S. 1987; Transcriptional activation by the E1A regions of adenovirus types 40 and 41. Virology 160:305–307 [CrossRef]
    [Google Scholar]
24. Xia L., Wang L., Chung A. S., Ivanov S. S., Ling M. Y., Dragoi A. M., Platt A. Gilmer T. M., Fu X.-Y., Chin Y. E. 2002; Identification of both positive and negative domains within the epidermal growth factor receptor COOH-terminal region for signal transducer and activator of transcription (STAT) activation. J Biol Chem 277:30716–30723 [CrossRef]
    [Google Scholar]
25. Young D. F., Andrejeva L., Livingstone A., Goodbourn S., Lamb R. A., Collins P. L., Elliott R. M., Randall R. E. 2003; Virus replication in engineered human cells that do not respond to interferons. J Virol 77:2174–2181 [CrossRef]
    [Google Scholar]